22 related articles for article (PubMed ID: 9873247)
1. IL-4 inhibits cell cycle progression of human umbilical vein endothelial cells by affecting p53, p21(Waf1), cyclin D1, and cyclin E expression.
Kim J; Cheon IS; Won YJ; Na HJ; Kim YM; Choe J
Mol Cells; 2003 Aug; 16(1):92-6. PubMed ID: 14503851
[TBL] [Abstract][Full Text] [Related]
2. Effects of low-to-moderate ethanol consumption on colonic growth and gene expression in young adult and middle-aged male rats.
Wells N; Quigley J; Pascua J; Pinkowski N; Almaiman L; Brasser SM; Hong MY
PLoS One; 2020; 15(12):e0243499. PubMed ID: 33326448
[TBL] [Abstract][Full Text] [Related]
3. Role of cyclin D1 immunoreactivity and AgNOR staining in the evaluation of benign and malignant lesions of the prostate.
Gupta V; Garg M; Chaudhry M; Singh S; Sen R; Gill M; Sangwaiya A
Prostate Int; 2014; 2(2):90-6. PubMed ID: 25032195
[TBL] [Abstract][Full Text] [Related]
4. p53 and cyclooxygenase-2 expression are directly associated with cyclin D1 expression in radical prostatectomy specimens of patients with hormone-naïve prostate cancer.
Vlachostergios PJ; Karasavvidou F; Patrikidou A; Voutsadakis IA; Kakkas G; Moutzouris G; Zintzaras E; Daliani DD; Melekos MD; Papandreou CN
Pathol Oncol Res; 2012 Apr; 18(2):245-52. PubMed ID: 21786090
[TBL] [Abstract][Full Text] [Related]
5. The AR dependent cell cycle: mechanisms and cancer relevance.
Schiewer MJ; Augello MA; Knudsen KE
Mol Cell Endocrinol; 2012 Apr; 352(1-2):34-45. PubMed ID: 21782001
[TBL] [Abstract][Full Text] [Related]
6. Epigenetics of prostate cancer: beyond DNA methylation.
Schulz WA; Hatina J
J Cell Mol Med; 2006; 10(1):100-25. PubMed ID: 16563224
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the histopathology and molecular pathology of carcinoma of the endometrium.
Burton JL; Wells M
Histopathology; 1998 Oct; 33(4):297-303. PubMed ID: 9822917
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 and p21 in ulcerative colitis-related inflammation and epithelial neoplasia: a study of aberrant expression and underlying mechanisms.
Wong NA; Mayer NJ; Anderson CE; McKenzie HC; Morris RG; Diebold J; Mayr D; Brock IW; Royds JA; Gilmour HM; Harrison DJ
Hum Pathol; 2003 Jun; 34(6):580-8. PubMed ID: 12827612
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of the expression of cell cycle regulating proteins: cyclin D1, P53 and P21 (WAF1) in colorectal cancer.
Pasz-Walczak G; Kordek R
Pol J Pathol; 2000; 51(2):63-9. PubMed ID: 10974928
[TBL] [Abstract][Full Text] [Related]
10. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone: P53 status has a strong impact on prognosis.
Suzuki Y; Nakano T; Kato S; Ohno T; Tsujii H; Oka K
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):231-6. PubMed ID: 15337561
[TBL] [Abstract][Full Text] [Related]
12. p21WAF1/Cip1 is associated with cyclin D1CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma.
Rey MJ; Fernández PL; Jares P; Muñoz M; Nadal A; Peiró N; Nayach I; Mallofré C; Muntané J; Campo E; Estapé J; Cardesa A
J Pathol; 1998 Mar; 184(3):265-71. PubMed ID: 9614378
[TBL] [Abstract][Full Text] [Related]
13. A clinicopathological study of p53, p21 (WAF1/CIP1) and cyclin D1 expression in human prostate cancers.
Shiraishi T; Watanabe M; Muneyuki T; Nakayama T; Morita J; Ito H; Kotake T; Yatani R
Urol Int; 1998; 61(2):90-4. PubMed ID: 9873247
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]